Endurance exercise training preserves cardiac function in rats receiving doxorubicin and the HER-2 inhibitor GW2974

Cancer Chemotherapy and Pharmacology

Volumn 64, Issue 6, 2009, Pages 1105-1113

  Wonders, Karen Y ^a   Hydock, David S ^b   Greufe, Stephanie ^b   Schneider, Carole M ^b   Hayward, Reid ^b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTHERN COLORADO   (United States)

Author keywords

Anthracyclines; Cardiotoxicity; Caspase; Heart; Physical activity

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 8; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2 INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; GW 2974; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DRUG DOSE INCREASE; ENDURANCE; ENZYME ACTIVITY; EXERCISE; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE; HEART PROTECTION; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BODY WEIGHT; CASPASE 3; CASPASE 8; DOXORUBICIN; EXERCISE THERAPY; FEMALE; HEART; HEART VENTRICLES; LIPID PEROXIDATION; MALONDIALDEHYDE; OXIDATIVE STRESS; QUINAZOLINES; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 69049117205     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-0967-z     Document Type: Article

References (51)

1. A Agarwal TM Said 2005 Oxidative stress, DNA damage and apoptosis in male infertility: a clinical approach BJU Int 95 503 507
2. M Akishita K Nagai H Xi W Yu N Sudoh T Watanabe M Ohara-Imaizumi S Nagamatsu K Kozaki M Horiuchi K Toba 2005 Renin-angiotensin system modulates oxidative stress-induced endothelial cell apoptosis in rats Hypertension 45 1188 1193
3. M Arai K Tomaru T Takizawa K Sekiguchi T Yokoyama T Suzuki R Nagai 1998 Sarcoplasmic reticulum genes are selectively down-regulated in cardiomyopathy produced by doxorubicin in rabbits J Mol Cell Cardiol 30 243 254
4. A Ascensao J Magalhaes J Soares R Ferreira M Neuparth F Marques J Oliveira J Duarte 2005 Endurance training attenuates doxorubicin-induced cardiac oxidative damage in mice Int J Cardiol 100 451 460
5. A Ascensao J Magalhaes JM Soares R Ferreira MJ Neuparth F Marques PJ Oliveira JA Duarte 2005 Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis Am J Physiol Heart Circ Physiol 289 H722 H731
6. J Baselga L Norton J Albanell YM Kim J Mendelsohn 1998 Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts Cancer Res 58 2825 2831
7. DA Brown KN Jew GC Sparagna TI Musch RL Moore 2003 Exercise training preserves coronary flow and reduces infarct size following ischemia-reperfusion in rat heart J Appl Physiol 25 2510 2518
8. AJ Chicco CM Schneider R Hayward 2005 Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart Am J Physiol Regul Integr Comp Physiol 289 R424 R431
9. AJ Chicco CM Schneider R Hayward 2006 Exercise training attenuates acute doxorubicin-induced cardiac dysfunction J Cardiovasc Pharmacol 47 182 189
10. SA Crone YY Zhao L Fan Y Gu S Minamisawa Y Liu KL Peterson J Chen R Kahn G Condorelli J Ross Jr KR Chien KF Lee 2002 ErbB2 is essential in the prevention of dilated cardiomyopathy Nat Med 8 459 465
11. EL de Beer AE Bottone MC van Rijk J van der Velden EE Voest 2002 Dexrazoxane pre-treatment protects skinned rat cardiac trabeculae against delayed doxorubicin-induced impairment of crossbridge kinetics Br J Pharmacol 135 1707 1714
12. GD Ehrlich FR Davey JJ Kirshner JJ Sninsky S Kwok DJ Slamon R Kalish BJ Poiesz 1989 A polyclonal CD4+ and CD8+ lymphocytosis in a patient doubly infected with HTLV-I and HIV-1: a clinical and molecular analysis Am J Hematol 30 128 139
13. MS Ewer MT Vooletich JB Durand ML Woods JR Davis V Valero DJ Lenihan 2005 Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment J Clin Oncol 23 7820 7826
14. C Fiorillo C Nediani V Ponziani L Giannini A Celli N Nassi L Formigli AM Perna P Nassi 2005 Cardiac volume overload rapidly induces oxidative stress-mediated myocyte apoptosis and hypertrophy Biochim Biophys Acta 1741 173 182
15. M Fukunaga S Miyata S Higo Y Hamada S Ueyama M Kasuga 2005 Methylglyoxal induces apoptosis through oxidative stress-mediated activation of p38 mitogen-activated protein kinase in rat Schwann cells Ann NY Acad Sci 1043 151 157
16. K Husain 2003 Interaction of physical training and chronic nitroglycerin treatment on blood pressure, nitric oxide, and oxidants/antioxidants in the rat heart Pharmacol Res 48 253 261
17. K Husain SM Somani TM Boley SR Hazelrigg 2003 Interaction of physical training and chronic nitroglycerin treatment on blood pressure and plasma oxidant/antioxidant systems in rats Mol Cell Biochem 247 37 44
18. DS Hydock CY Lien CM Schneider R Hayward 2008 Exercise preconditioning protects against doxorubicin-induced cardiac dysfunction Med Sci Sports Exerc 40 808 817
19. H Jin R Yang W Li H Lu AM Ryan AK Ogasawara J Van Peborgh NF Paoni 2000 Effects of exercise training on cardiac function, gene expression, and apoptosis in rats Am J Physiol Heart Circ Physiol 279 H2994 H3002
20. H Joensuu PL Kellokumpu-Lehtinen P Bono T Alanko V Kataja R Asola T Utriainen R Kokko A Hemminki M Tarkkanen T Turpeenniemi-Hujanen S Jyrkkio M Flander L Helle S Ingalsuo K Johansson AS Jaaskelainen M Pajunen M Rauhala J Kaleva-Kerola T Salminen M Leinonen I Elomaa J Isola 2006 Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer N Engl J Med 354 809 820
21. B Kalyanaraman J Joseph S Kalivendi S Wang E Konorev S Kotamraju 2002 Doxorubicin-induced apoptosis: implications in cardiotoxicity Mol Cell Biochem 234-235 119 124
22. N Kobayashi FA Delano GW Schmid-Schonbein 2005 Oxidative stress promotes endothelial cell apoptosis and loss of microvessels in the spontaneously hypertensive rats Arterioscler Thromb Vasc Biol 25 2114 2121
23. D Kumar LA Kirshenbaum T Li I Danelisen PK Singal 2001 Apoptosis in adriamycin cardiomyopathy and its modulation by probucol Antioxid Redox Signal 3 135 145
24. Y Kuramochi GM Cote X Guo NK Lebrasseur L Cui R Liao DB Sawyer 2004 Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1beta/erbB4 signaling J Biol Chem 279 51141 51147
25. KF Lee H Simon H Chen B Bates MC Hung C Hauser 1995 Requirement for neuregulin receptor erbB2 in neural and cardiac development Nature 378 394 398
26. V Lee AK Randhawa PK Singal 1991 Adriamycin-induced myocardial dysfunction in vitro is mediated by free radicals Am J Physiol 261 H989 H995
27. FF Liu JR Stone AJ Schuldt K Okoshi MP Okoshi M Nakayama KK Ho WJ Manning MA Marchionni BH Lorell JP Morgan X Yan 2005 Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure Am J Physiol Heart Circ Physiol 289 H660 H666
28. G Minotti P Menna E Salvatorelli G Cairo L Gianni 2004 Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity Pharmacol Rev 56 185 229
29. C Ozcelik B Erdmann B Pilz N Wettschureck S Britsch N Hubner KR Chien C Birchmeier AN Garratt 2002 Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy Proc Natl Acad Sci USA 99 8880 8885
30. S Paik J Bryant E Tan-Chiu G Yothers C Park DL Wickerham N Wolmark 2000 HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15 J Natl Cancer Inst 92 1991 1998
31. MD Pegram A Lipton DF Hayes BL Weber JM Baselga D Tripathy D Baly SA Baughman T Twaddell JA Glaspy DJ Slamon 1998 Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment J Clin Oncol 16 2659 2671
32. EA Perez R Rodeheffer 2004 Clinical cardiac tolerability of trastuzumab J Clin Oncol 22 322 329
33. EA Perez VJ Suman NE Davidson GW Sledge PA Kaufman CA Hudis S Martino JR Gralow SR Dakhil JN Ingle EP Winer KA Gelmon BJ Gersh AS Jaffe RJ Rodeheffer 2008 Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial J Clin Oncol 26 1231 1238
34. S Phaneuf C Leeuwenburgh 2001 Apoptosis and exercise Med Sci Sports Exerc 33 393 396
35. MJ Piccart-Gebhart M Procter B Leyland-Jones A Goldhirsch M Untch I Smith L Gianni J Baselga R Bell C Jackisch D Cameron M Dowsett CH Barrios G Steger CS Huang M Andersson M Inbar M Lichinitser I Lang U Nitz H Iwata C Thomssen C Lohrisch TM Suter J Ruschoff T Suto V Greatorex C Ward C Straehle E McFadden MS Dolci RD Gelber 2005 Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer N Engl J Med 353 1659 1672
36. MC Pinder Z Duan JS Goodwin GN Hortobagyi SH Giordano 2007 Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer J Clin Oncol 25 3808 3815
37. SK Powers D Criswell J Lawler D Martin FK Lieu LL Ji RA Herb 1993 Rigorous exercise training increases superoxide dismutase activity in ventricular myocardium Am J Physiol 265 H2094 H2098
38. SK Powers HA Demirel HK Vincent JS Coombes H Naito KL Hamilton RA Shanely J Jessup 1998 Exercise training improves myocardial tolerance to in vivo ischemia-reperfusion in the rat Am J Physiol 275 R1468 R1477
39. KI Pritchard LE Shepherd FP O'Malley IL Andrulis D Tu VH Bramwell MN Levine 2006 HER2 and responsiveness of breast cancer to adjuvant chemotherapy N Engl J Med 354 2103 2111
40. T Pugatsch S Abedat C Lotan R Beeri 2006 Anti-erbB2 treatment induces cardiotoxicity by interfering with cell survival pathways Breast Cancer Res 8 R35
41. J Quindry J French K Hamilton Y Lee JL Mehta S Powers 2005 Exercise training provides cardioprotection against ischemia-reperfusion induced apoptosis in young and old animals Exp Gerontol 40 416 425
42. EH Romond EA Perez J Bryant VJ Suman CE Geyer Jr NE Davidson E Tan-Chiu S Martino S Paik PA Kaufman SM Swain TM Pisansky L Fehrenbacher LA Kutteh VG Vogel DW Visscher G Yothers RB Jenkins AM Brown SR Dakhil EP Mamounas WL Lingle PM Klein JN Ingle N Wolmark 2005 Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med 353 1673 1684
43. DW Rusnak K Affleck SG Cockerill C Stubberfield R Harris M Page KJ Smith SB Guntrip MC Carter RJ Shaw A Jowett J Stables P Topley ER Wood PS Brignola SH Kadwell BR Reep RJ Mullin KJ Alligood BR Keith RM Crosby DM Murray WB Knight TM Gilmer K Lackey 2001 The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer Cancer Res 61 7196 7203
44. A Seidman C Hudis MK Pierri S Shak V Paton M Ashby M Murphy SJ Stewart D Keefe 2002 Cardiac dysfunction in the trastuzumab clinical trials experience J Clin Oncol 20 1215 1221
45. R Seshadri FA Firgaira DJ Horsfall K McCaul V Setlur P Kitchen 1993 Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group J Clin Oncol 11 1936 1942
46. PM Siu RW Bryner JK Martyn SE Alway 2004 Apoptotic adaptations from exercise training in skeletal and cardiac muscles Faseb J 18 1150 1152
47. DJ Slamon B Leyland-Jones S Shak H Fuchs V Paton A Bajamonde T Fleming W Eiermann J Wolter M Pegram J Baselga L Norton 2001 Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 783 792
48. SM Swain FS Whaley MS Ewer 2003 Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials Cancer 97 2869 2879
49. E Tan-Chiu G Yothers E Romond CE Geyer Jr M Ewer D Keefe RP Shannon SM Swain A Brown L Fehrenbacher VG Vogel TE Seay P Rastogi EP Mamounas N Wolmark J Bryant 2005 Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31 J Clin Oncol 23 7811 7819
50. RP Taylor JT Ciccolo JW Starnes 2003 Effect of exercise training on the ability of the rat heart to tolerate hydrogen peroxide Cardiovasc Res 58 575 581
51. M Venturini C Bighin S Monfardini F Cappuzzo N Olmeo A Durando F Puglisi O Nicoletto A Lambiase L Del Mastro 2006 Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer Breast Cancer Res Treat 95 45 53